Mahmut Emre Yıldırım

13PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 24, 2026
Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study.

|Jan 28, 2026
Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study.

İlker Nihat Ökten, Tuba Baydaş, Mahmut Emre Yıldırım

|May 06, 2025
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.

Sedat Yıldırım, Tugba Başoğlu, Akif Doğan

|Jan 25, 2025
Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study.

Akif Doğan, Nurullah İlhan, Goncagül Akdağ

|Oct 26, 2024
Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older.

Deniz Isik, Özkan Alan, Goncagül Akdağ

|Sep 09, 2024
Evaluation of emergency department visits and immune-related adverse effects (irAEs) in patients treated with nivolumab.

Emre Kudu, Goncagul Akdag, Mahmut Emre Yildirim

Pageof 3

Frequent Collaborators

9 joint publications

Goncagul Akdag

9 joint publications

Sedat Yıldırım

9 joint publications

Hatice Odabas

8 joint publications

Oğuzcan Kınıkoğlu